•
Mar 31, 2023

AMN Healthcare Q1 2023 Earnings Report

AMN Healthcare's Q1 2023 financial performance was marked by a revenue decrease compared to the previous year, but demonstrated resilience through strategic initiatives and investments in technology.

Key Takeaways

AMN Healthcare announced its first quarter 2023 financial results with a revenue of $1.126 billion, a 27% decrease from prior year. GAAP EPS was $2.02 and adjusted EPS was $2.49. The company is focusing on sustainable workforce solutions and investing in technology enhancements.

Consolidated revenue for the quarter was $1.126 billion, a 27% decrease from prior year.

Net income was $84 million, or $2.02 per diluted share, compared with $146 million, or $3.09 per diluted share, in the first quarter of 2022.

Adjusted diluted EPS in the first quarter was $2.49 compared with $3.49 in the same quarter a year ago.

The company spent $225 million year to date to repurchase approximately 2.4 million shares of its common stock.

Total Revenue
$1.13B
Previous year: $1.55B
-27.5%
EPS
$2.49
Previous year: $3.49
-28.7%
Gross Profit
$369M
Previous year: $496M
-25.7%
Cash and Equivalents
$29M
Previous year: $113M
-74.3%
Free Cash Flow
$25.9M
Previous year: $187M
-86.1%
Total Assets
$2.88B
Previous year: $3.25B
-11.3%

AMN Healthcare

AMN Healthcare

AMN Healthcare Revenue by Segment

Forward Guidance

Revenue in the second quarter of 2023 is expected to be 30-32% lower than prior year and 11-14% lower sequentially.

Challenges Ahead

  • Nurse and Allied Solutions segment revenue is expected to be down 36-38% year over year.
  • Physician and Leadership Solutions segment revenue is expected to be down approximately 5% year over year.
  • For the Technology and Workforce Solutions segment, revenue is expected to be approximately 15% lower year over year.